Schedule 13D ownership disclosure

TC BioPharm (Holdings) plc

Security class unavailable · CUSIP: 87807D103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,432,683
Percent of class
15.7900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-22-002973
Form type
SC 13D
Filer
Scottish Enterprise
CIK
CIK 1731442
Filed
Feb 22, 2022
Reporting period
—
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub